SCIENCE TRIBUNE
The KBO register records legal situation 013 for SCIENCE TRIBUNE (Register: dissolution or liquidation); this is today's state according to the register itself, which carries no start date. The 2023 annual accounts show equity of €272k and a net result of €190k.
| Equity | €272k |
| Net result | €190k |
| Better than sector | 38% |
| Active | 18 yrs |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Dissolution or liquidation
The KBO register records that this company is being wound up. A twelve-month bankruptcy probability no longer says anything in that case, so we show no figure.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 15.3% | 26.3% | |
| Net result | €190k | €23k | |
| Equity | €272k | €148k | |
| Gross operating margin | €237k | €178k | |
| Total assets | €1.78M | €889k |
Show 10 other metrics
| Fiscal year | 2023 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €237k |
| Net profit | €190k |
| Cash flow | €218k |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €1.78M |
| Equity | €272k |
| Debt | €1.51M |
| of which ≤ 1y | €1.36M |
| of which > 1y | €143k |
| Working capital | €158k |
| Employees (FTE) | - |
| 2023 | |
|---|---|
| Current ratio | 1.12 |
| Quick ratio | 1.12 |
| Working capital ratio | 8.9% |
| Solvency | 15.3% |
| Debt / equity | 5.55 |
| Long-term debt ratio | 0.52 |
| Interest coverage | 12.82 |
| Gross margin | - |
| Net margin | - |
| ROA | 10.7% |
| ROE | 69.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.78M |
| Fixed assets | 21/28 | €262k |
| Intangible fixed assets | 21 | €257k |
| Financial fixed assets | 28 | €6k |
| Current assets | 29/58 | €1.52M |
| Amounts receivable within one year | 40/41 | €1.33M |
| Cash & bank | 54/58 | €177k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.78M |
| Equity | 10/15 | €272k |
| Contributions / capital | 10/11 | €494k |
| Reserves | 13 | €12k |
| Accumulated profits (losses) | 14 | €-234k |
| Amounts payable | 17/49 | €1.51M |
| Amounts payable after one year | 17 | €143k |
| Amounts payable within one year | 42/48 | €1.36M |
| Income statement | ||
| Gross operating margin | 9900 | €237k |
| Operating result | 9901 | €208k |
| Financial income | 75 | €125 |
| Financial charges | 65 | €18k |
| Result before taxes | 9903 | €190k |
| Net result for the period | 9904 | €190k |
| Result to be appropriated | 9905 | €190k |
-
Inge BerckmansDirectorState Gazette act 22133218 (10-11-2022)Current10-11-2022 → present
-
Olaf BeckersDirectorState Gazette act 22133218 (10-11-2022)Current10-11-2022 → present
-
Peter GoossensManaging directorState Gazette act 22133218 (10-11-2022)Current10-11-2022 → present
| NACE primary | Handelsbemiddeling in de groothandel in andere specifieke goederen(46180) |
| Legal form | Public limited company(014) |
| Incorporation | 23-10-2007 |
| Status | Active |
| Postal code | 3900 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72502E0102/00R133 | Flanders | 4,707 m² | 1 · 1,348 m² | 8.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 10 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
23-11-2023 Capital increase of €160,000 to €494,000
- €334.000 → €494.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 494000.0,
"delta_eur": 160000.0,
"before_eur": 334000.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "GOOSSENS Peter",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": null,
"contribution_amount_eur": 160000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 160000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "stemgerechtigde",
"n_new_shares": 3340,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "stemgerechtigde",
"n_new_shares": 3340,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Katrijn Conjaerts",
"firm_city": null,
"firm_name": null,
"office_city": "Pelt",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-11-23",
"filing_date": "2023-11-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2023-11-15",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2023-11-15"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0893.010.704",
"name_full": "SCIENCE TRIBUNE",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van de akte- geco\u00F6rdineerde statuten"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "GOOSSENS Peter",
"role": "aandeelhouder",
"n_shares": 3340,
"share_class": "stemgerechtigde"
}
],
"share_classes_after": [
{
"n_shares": 3340,
"class_name": "stemgerechtigde",
"capital_share_eur": 494000.0,
"voting_rights_per_share": 1.0
}
]
}10-11-2022 3 directors appointed
- Inge Berckmans, Bestuurder
- Olaf Beckers, Bestuurder
- Peter Goossens, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Inge Berckmans",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olaf Beckers",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Peter Goossens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-11-10",
"filing_date": "2022-10-27",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "bijzondere_algemene_vergadering",
"date": "2022-09-29",
"unanimous": false
}
],
"is_correction": false,
"subject_company": {
"kbo": "0893.010.704",
"name_full": "Science Tribune",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}| Legal nameNL | SCIENCE TRIBUNE |